Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676195 · ClinicalTrials.gov registry record · Phase 2
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00676195: Completed Phase 2 study, sponsored by Stanford University.
NCT00676195 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676195, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism.
Interventions
- DRUG N-Acetyl Cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676195
The ClinicalTrials.gov registry entry for NCT00676195 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N-Acetyl Cysteine is the first listed.
NCT00676195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676195 about?
NCT00676195 is a clinical study titled "An Open-Label Study of N-Acetyl Cysteine in Children With Autism". The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism.
What is the current status of trial NCT00676195?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2008-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00676195?
The interventions under investigation include: N-Acetyl Cysteine (DRUG).
Who is sponsoring clinical trial NCT00676195?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.